Key facts
- It has raised $120K; the latest was Early Stage VC in Jan 2025.
- Notable investors include European Innovation Council, NLC Health Ventures, Ascenion, German Accelerator, Grow Ventures Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for POROUS
- ·The full record, as it builds
Funding rounds
No funding rounds for POROUS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About POROUS
Developer of an ultrasound system designed for the early detection and assessment of osteoporosis. The company system offers a non-invasive analysis by using quantitative ultrasound technology with patented intelligent algorithms that can measure the cortical bone quality to a microscopic pore level without radiation hazards, enabling primary care physicians with routine screenings and early detection.
- Sector
- Healthcare
- HQ
- Potsdam, Germany
- Employees
- 17
- Website
- porous.care/
- Ownership
- Privately Held (backing)
POROUS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in POROUS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on POROUS in its N-PORT filings yet. We sweep new filings monthly.